 |
인쇄하기
취소
|
Janssen starts selling Yondelis in Korea
Janssen Korea says it will start selling Yondelis (trabectedin), a treatment for soft-tissue sarcoma, from November 25. Yondelis will be the first new therapy to be commercialized in this indication in the last two decades.
Yondelis was originally isolated from the marine tunicate Ecteinascidia turbinata. Yondelis has a novel mechanism of action. It is a unique anti cancer agent that binds i...
Yondelis was originally isolated from the marine tunicate Ecteinascidia turbinata. Yondelis has a novel mechanism of action. It is a unique anti cancer agent that binds i...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.